New Delhi, November 16, 2026 (Yes Punjab News)
The Food Safety and Standards Authority of India (FSSAI) has taken regulatory action against multiple nutraceutical manufacturers, including suspending licences, after inspections revealed significant food safety and regulatory violations.
The action follows increased scrutiny of the fast-growing nutraceutical sector. Recent inspections identified non-compliance involving product formulations, labelling, hygiene and manufacturing practices.
FSSAI named six companies facing action: Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare and Vedant Remedies.
At Airen Herbals, inspectors found that its product ‘Lycowey Syrup’ contained thiamin, vitamin E acetate, copper, selenium and zinc at levels exceeding the prescribed Recommended Dietary Allowance (RDA) limits per serving. Its ‘Maxford Pain Relief’ product was also flagged for unauthorised claims related to knee relief, use of pain-relief imagery and non-compliance in botanical ingredient declarations.
Inspections at Aquabliss Lifesciences revealed expired raw materials at the manufacturing site and inadequate sanitation and hygiene. Raskam Healthcare was cited for using Shilajit, an ingredient not approved for the identified products, along with deficiencies in record-keeping and documentation.
At Supercure Biotech, FSSAI found that ‘Gemkolin 9G softgel capsules’ contained biotin above the maximum permitted limit. Another product marketed as a vitamin E softgel capsule contained wheat germ oil instead of vitamin E, according to the regulator. The company was also flagged for labelling deficiencies and non-permitted and pathogenic microbial strains in its probiotic products.
Ambico Ayurvedic Healthcare was found to be using expired materials in nutraceutical preparations and maintaining inadequate hygiene at its manufacturing premises. At Vedant Remedies, inspectors detected expired materials in flavouring products, along with shortcomings in sanitation, housekeeping, manufacturing infrastructure and testing facilities.




























